BOLD - Audentes Therapeutics Inc. (BOLD) CEO Matt Patterson on Q3 2019 Results - Earnings Call Transcript
Audentes Therapeutics, Inc. (BOLD)
Q3 2019 Earnings Conference Call
November 7, 2019 16:30 ET
Company Participants
Andrew Chang - Head, IR
Matt Patterson - Chairman & CEO
Natalie Holles - President & COO
Conference Call Participants
Dae Gon - SVB Leerink
Chris Raymond - Piper Jaffray
Anupam Rama - JPMorgan
Steve Seedhouse - Raymond James
Rajiv Prasad - William Blair
Matthew Luchini - BMO Capital Market
Presentation
Operator
Good afternoon ladies and gentlemen and welcome to the Audentes Therapeutics Third Quarter 2019 Earnings Conference Call. [Operator Instructions]
I would now like to turn the call